Exact Sciences Corp. (EXAS): Price and Financial Metrics
EXAS Price/Volume Stats
| Current price | $58.85 | 52-week high | $100.77 |
| Prev. close | $58.79 | 52-week low | $56.05 |
| Day low | $58.45 | Volume | 2,019,000 |
| Day high | $60.31 | Avg. volume | 2,286,794 |
| 50-day MA | $63.28 | Dividend yield | N/A |
| 200-day MA | $70.10 | Market Cap | 10.68B |
EXAS Stock Price Chart Interactive Chart >
Exact Sciences Corp. (EXAS) Company Bio
Exact Sciences Corp. is a molecular diagnostics company specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer, in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer. (Source:Wikipedia)
Latest EXAS News From Around the Web
Below are the latest news stories about EXACT SCIENCES CORP that investors may wish to consider to help them evaluate EXAS as an investment opportunity.
Exact Sciences Corporation (NASDAQ:EXAS) Shares Could Be 31% Below Their Intrinsic Value EstimateKey Insights The projected fair value for Exact Sciences is US$107 based on 2 Stage Free Cash Flow to Equity Exact... |
Exact Sciences' (EXAS) Solid Cologuard Sales, Innovation AidFollowing the acquisitions of Paradigm and Ashion, Exact Sciences (EXAS) is offering therapy selection tests for patients with advanced cancer. |
1 Supercharged Growth Stock to Buy Before It Soars as Much as 222%, According to Cathie Wood's Ark InvestIf the fund manager's calculations prove to be correct, shareholders could enjoy threefold returns over the coming four years. Is she right? |
Ark Invest Stock Portfolio: 16 Biggest PositionsIn this article, we discuss the 16 biggest positions in the ARK Invest portfolio. If you want to read about some more stocks in the ARK Invest portfolio, go directly to Ark Invest Stock Portfolio: 5 Biggest Positions. Catherine D. Wood, although relatively new to the industry, stands out as a somewhat controversial hedge fund […] |
Here's Why You Should Retain Exact Sciences (EXAS) Stock NowInvestors are optimistic about Exact Sciences (EXAS) on strong Cologuard adoption and raised guidance. |
EXAS Price Returns
| 1-mo | -14.78% |
| 3-mo | -8.45% |
| 6-mo | -0.36% |
| 1-year | -8.15% |
| 3-year | -56.70% |
| 5-year | -40.04% |
| YTD | -20.45% |
| 2023 | 49.42% |
| 2022 | -36.39% |
| 2021 | -41.26% |
| 2020 | 43.26% |
| 2019 | 46.56% |
Continue Researching EXAS
Want to do more research on Exact Sciences Corp's stock and its price? Try the links below:Exact Sciences Corp (EXAS) Stock Price | Nasdaq
Exact Sciences Corp (EXAS) Stock Quote, History and News - Yahoo Finance
Exact Sciences Corp (EXAS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...